Email this page: News Release

Celsion and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer

To (email address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:   Copy yourself These email addresses will be used to email the page on your behalf and will not be used by Celsion Corporation for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Celsion Corporation prevent automated submissions.